Auvelity (Dextromethorphan-Bupropion) for Agitation and Aggression in Alzheimer's Disease Dementia: Mechanism, Efficacy, Safety, and Clinical Considerations.

Sarangal M, Sarangal C, Vora J, Soni K

Open source

DOI
10.64719/pb.20773
Published
2026 Sep 18
Container
Psychopharmacology bulletin
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.64719/pb.20773,
  title = {Auvelity (Dextromethorphan-Bupropion) for Agitation and Aggression in Alzheimer's Disease Dementia: Mechanism, Efficacy, Safety, and Clinical Considerations.},
  author = {Sarangal M and Sarangal C and Vora J and Soni K},
  year = {2026},
  journal = {Psychopharmacology bulletin},
  doi = {10.64719/pb.20773},
  url = {https://doi.org/10.64719/pb.20773}
}

RIS

TY  - JOUR
TI  - Auvelity (Dextromethorphan-Bupropion) for Agitation and Aggression in Alzheimer's Disease Dementia: Mechanism, Efficacy, Safety, and Clinical Considerations.
AU  - Sarangal M
AU  - Sarangal C
AU  - Vora J
AU  - Soni K
PY  - 2026
JO  - Psychopharmacology bulletin
DO  - 10.64719/pb.20773
UR  - https://doi.org/10.64719/pb.20773
ER  - 

APA

M, S., C, S., J, V., & K, S. (2026). Auvelity (Dextromethorphan-Bupropion) for Agitation and Aggression in Alzheimer's Disease Dementia: Mechanism, Efficacy, Safety, and Clinical Considerations.. Psychopharmacology bulletin. https://doi.org/10.64719/pb.20773

Source records